BASI Key Stats
| Income Statement | |
| Revenue TTM | 26.50M |
| Revenue Quarterly YoY Growth | -22.79% |
| EPS Diluted TTM | -0.6625 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -4.76M |
| Profitability | |
| Gross Profit Margin Quarterly | 31.97% |
| Profit Margin Quarterly | 2.40% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 10.53M |
| Enterprise Value | 17.84M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 1.240 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.6751 |
| Free Cash Flow | 0.692M |
| Return on Equity | -48.26% |
BASI News
- Bioanalytical Systems' CEO Discusses F2Q13 Results - Earnings Call Transcript Seeking Alpha May 15
- Bioanalytical Systems Inc Earnings Call scheduled for 11:00 am ET today May 15
- Bioanalytical Systems (BASI) Posts Q2 Loss of 2c/Share Street Insider May 15
- BASi Reports Second Quarter Results Business Wire May 15
- Q2 2013 Bioanalytical Systems Inc Earnings Release - 08:30 am ET May 15
- BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financia... May 15
- BIOANALYTICAL SYSTEMS INC Files SEC form 8-K/A, Submission of Matters to a Vote ... May 14
- Bioanalytical Systems to Release Second Quarter Results Wednesday, May 15, 2013;... May 9
- BASi Launches Innovative Glucose Monitoring Project With Pinnacle Technology Business Wire May 2
- BASi Launches Innovative Glucose Monitoring Project with Pinnacle Technology noodls May 1
BASI Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Bioanalytical Systems is up 16.65% over the last year vs S&P 500 Total Return up 31.68%, Agilent Technologies up 18.88%, and SurModics up 84.69%.
BASI Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these BASI related companies
Pro Ratings for BASI
Pro Report PDF for BASI
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download BASI Pro Report PDF
Pro Strategies Featuring BASI
Did Bioanalytical Systems make it into our Pro Portfolio Strategies?
BASI Profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Diagnostics & Research
Other BASI Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BASI | 1.373 | +0.00 | +0.15% | 10.53M |
